NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Innovision IPO Day 2: Subscription Update

The initial public offering (IPO) of Innovision, a provider of manpower and toll plaza management services, entered its second day on March 11. The IPO, which opened for bidding on March 10, saw a tepid response from investors on the first day, with just 2% of the shares bid.

Key IPO Details

  • ₹521 to ₹548 per share: fixed IPO price band
  • ₹323 crore: total IPO size
  • ₹255 crore: fresh issue of shares
  • 12,38,000 equity shares: offer-for-sale of shares
  • ₹27 per share: minimum application lot size

Read also: SMR Jewels IPO Successfully Lists with Institutional Support

Subscription Update

As of the end of the first day, the Innovision IPO was booked at 2%. The qualified institutional buyer (QIB) segment was subscribed the most at 96%, while the non-institutional investor (NII) quota saw no bids. The retail portion was subscribed at 2%.

Grey Market Premium

The grey market premium for Innovision IPO remains weak, with a nil premium according to investorgain.com. This means that Innovision shares are trading at par with the IPO price.

Read also: Zepto Nears $1 Billion Quarterly Net Order Value Milestone Before IPO

Listing Date

Shares of Innovision IPO are slated to list on both BSE and NSE on March 17.

Brokerage Views

Brokerages have largely assigned an 'Avoid' rating to Innovision IPO amid high valuations and weak margins. SBI Securities noted that the issue is valued at a P/E ratio of 32.5x based on its 1HFY26 annualised earnings on post-issue capital. Swastika Investmart also expressed concerns about the IPO's valuation, citing thin margins and a commoditised business.

Investor Takeaway

Investors should be cautious of the tepid demand for Innovision's IPO.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.